All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Orphan drug designation granted to a FasTCAR dual-targeting CAR T-cell, GC012F, for the treatment of R/R MM
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GC012F, a FasTCAR-enabled B-cell maturation antigen...
Nov 25, 2021
|RRMM
María-Victoria Mateos
"The MM Hub is the ideal platform for the latest news about myeloma. You will find information about the most recent data, and also personal experiences from experts managing myeloma patients in their clinical practice."